Drugmaker Egalet pursues restructuring through equity swap and acquisition
A Delaware bankruptcy judge has allowed US and UK companies in the pharma group Egalet to use lender cash to fund their operations, as they go through Chapter 11 to carry out a debt-to-equity swap and acquire a Philadelphia painkiller producer.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10